Skip to main content
PMC home page
Frontiers in Aging Neuroscience logoLink to Frontiers in Aging Neuroscience
. 2022 Jun 15;14:892518. doi: 10.3389/fnagi.2022.892518

Towards Understanding the Relationship Between ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis

Chenxuan Zhao 1, Yong Liao 2,*, Abdul Rahaman 3, Vijay Kumar 4,*,†
PMCID: PMC9248913  PMID: 35783140

Abstract

Biological stress due to the aberrant buildup of misfolded/unfolded proteins in the endoplasmic reticulum (ER) is considered a key reason behind many human neurodegenerative diseases. Cells adapted to ER stress through the activation of an integrated signal transduction pathway known as the unfolded protein response (UPR). Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by degeneration of the motor system. It has largely been known that ER stress plays an important role in the pathogenesis of ALS through the dysregulation of proteostasis. Moreover, accumulating evidence indicates that ER stress and UPR are important players in TDP-43 pathology. In this mini-review, the complex interplay between ER stress and the UPR in ALS and TDP-43 pathology will be explored by taking into account the studies from in vitro and in vivo models of ALS. We also discuss therapeutic strategies to control levels of ER stress and UPR signaling components that have contrasting effects on ALS pathogenesis.

Keywords: ER stress, UPR, ALS, TDP-43, pharmacological modulator

Introduction

Amyotrophic lateral sclerosis (ALS), the most common type of motor neuron disease, is characterized by the progressive degeneration of both lower and upper motor neurons and eventually leads to death due to respiratory failure, typically within 2–5 years of symptom onset (van Es et al., 2017). While the majority of cases are sporadic (sALS), approximately 10% of ALS is inherited, usually in an autosomal dominant fashion (fALS). The proposed pathomechanisms of ALS include oxidative stress, dysfunction in mitochondria and axonal transport, excitotoxicity, damage to protein homeostasis, etc. (Ferraiuolo et al., 2011; Kumar et al., 2016a; Tsai and Manley, 2021). Studies of fALS cases have revealed several ALS-associated genes (Cooper-Knock et al., 2021; Shatunov and Al-Chalabi, 2021) which are involved in several important cellular and biological processes. Many of the fALS- genes have also been involved in different facets of the proteostasis network. Abnormal accumulation of misfolded or aggregated proteins to proteinaceous inclusions represents a common unifying pathological feature of ALS (Lin et al., 2017; Webster et al., 2017; Cicardi et al., 2021). These intracellular inclusions are found in both degenerating neurons and surrounding glia (Nishihira et al., 2009; Dugger and Dickson, 2017) as well as present in the different regions of the brain including the spinal cord, cerebellum, brainstem, hippocampus, and the frontal and temporal lobes (Al-Chalabi et al., 2012). The most predominant inclusions observed in the motor neurons are of ubiquitinated proteins (Neumann et al., 2006), thus indicating the defects in protein homeostasis (Blokhuis et al., 2013). Ubiquitinated protein inclusions of Tar DNA-binding protein of 43 kDa (TDP-43) are positive for the majority of ALS cases (Arai et al., 2006; Neumann et al., 2006). TDP-43 was also identified as the pathological protein in a subset of neurodegenerative diseases commonly known as TDP-43 proteinopathies (Tziortzouda et al., 2021). In these diseases, the loss of nuclear TDP-43 and cytoplasmic inclusions of TDP-43 result in either loss or gain-of-function within neurons and affect several biological processes like autophagy, RNA synthesis, the ubiquitin-proteasome system, and axonal transport (Prasad et al., 2019). Several studies also indicate that endoplasmic reticulum (ER) stress plays a critical role in TDP-43 proteinopathies (Walker and Atkin, 2011; Walter and Ron, 2011; Walker et al., 2013; de Mena et al., 2021). Besides the presence of TDP-43 inclusions, inclusions for mutant Cu/Zn superoxide dismutase (SOD1) and fused in sarcoma protein (FUS) are also found in ALS patients (Mackenzie et al., 2007; Kwiatkowski et al., 2009; Vance et al., 2009). The other fALS-associated mutant proteins that aggregates are valosin-containing protein (VCP), dynactin-1 (DCTN1), optineurin (OPTN), and ubiquilin-2 (UBQLN2; Levy et al., 2006; Maruyama et al., 2010; Deng et al., 2011; Koppers et al., 2012). The characteristic observation of the protein aggregates is indicative of the breakdown of proteostasis in ALS. Consequently, a key proteostatic pathway identified as the Unfolded Protein Response (UPR) responds to the endoplasmic reticulum (ER) stress-induced protein aggregation by initiating either proadaptive and/or proapoptotic pathways. In this mini-review, we aim to provide insights into the complex interplay between ER stress, UPR, and TDP-43 in the context of ALS.

ER Stress and UPR Pathway

The ER is a membranous organelle involved in protein folding, post-translational modifications, and trafficking, and synthesizes about one-third of the total proteome (Schroder, 2008; Bernard-Marissal et al., 2015). Despite the quality control accomplished by ER chaperones to ensure proper folding and maturation of newly synthesized proteins, protein maturation mechanisms are sometimes perturbed which leads to the correct folding success in the cell to be under 20% (Kaushik and Cuervo, 2015). These misfolded/unfolded proteins are retained in the ER and are susceptible to undergoing proteasomal degradation through the ER-associated degradation (ERAD) pathway that recognizes, ubiquitinates, and relocates misfolded proteins to the cytosol for their degradation (Oakes and Papa, 2015). However, disruption of ER-calcium homeostasis, abnormal proteostasis, hypoxia, etc., decrease the protein-folding ability leading to ER stress (Lin et al., 2008). Upon detection of ER stress, the ER initiates UPR that decreases the burden of misfolded proteins and re-establishes proteostasis. This cellular response is achieved through coordinated transcriptional and translational activities, the increased expression of chaperones in the ERAD pathway, and a brief decrease in the protein flux entering the ER. The UPR has three proximal transmembrane protein sensors: Inositol-requiring kinase/endoribonuclease (IRE1), double-stranded RNA-activated protein kinase (PKR)-like ER kinase (PERK), and activating transcription factor 6 (ATF6) (Schroder, 2008; Hetz, 2012). Both IRE-1 and PERK are type I transmembrane proteins having kinase activity (Liu et al., 2002). On the other hand, ATF6 is a type II transmembrane protein, and its cytosolic domain can enter the nucleus and thus can activate UPR related genes (Haze et al., 1999). The UPR attempts to restore proteostasis by decreasing translation, increasing chaperones assisted protein folding, and up-regulation of ERAD and autophagy to get rid of misfolded proteins. If ER stress is brief, the UPR pathways work in parallel to organize a series of pro-adaptive cascades to restore proteostasis and the cell survives. However, in case of severe prolonged ER stress, the UPR activates the pro-apoptotic pathway (Figure 1; Hetz and Saxena, 2017; Hetz and Papa, 2018).

Figure 1.

Figure 1

Open in a new tab

Unfolded protein response (UPR) pathways in the ER and small molecule interventions. Upon ER stress, the ER launches three adaptive pathways through IRE1α, PERK, and activating transcription factor 6 (ATF6), collectively called as the UPR, to restore proteostasis. All these three ER stress sensors activate signaling cascades, increasing protein-folding ability and decreasing ER stress. Small molecules targeting three key UPR signaling components are also indicated in the figure suggesting the sites for therapeutic interventions. Adapted and modified from Webster et al. (2017).

An immediate adaptive reaction to ER stress is started by translocation of ATF6 to the nucleus, where it modulates the genes involved in protein homeostasis (Haze et al., 1999). IRE1 by mediating the splicing of a transcription factor, X-Box-Binding protein 1 (XBP1), activates several genes of the protein homeostasis pathway along with the release of ERAD proteins (Acosta-Alvear et al., 2007). Whereas, PERK phosphorylates the eukaryotic initiation factor 2α (eIF2α), and thus decreases protein translation by overpowering a load of misfolded proteins (Harding et al., 1999). Also, eIF2α activates ATF4 which subsequently activates many UPR-targeted genes (Tabas and Ron, 2011). Ultimately, the UPR reduced the translation and increased the expression of genes of protein homeostasis including chaperones and ERAD proteins. Also, disruption of ER homeostasis leads to the activation of apoptotic pathways (Malhotra and Kaufman, 2007; Krebs et al., 2015).

ER Stress and UPR in ALS

Long-term ER stress is a critical factor affecting cell survival in neurodegenerative diseases characterized by severe proteostatic imbalances (Scheper and Hoozemans, 2015). Many studies have reported the presence of ER stress in ALS and FTD patient’s tissue samples, as well as cellular and animal models of fALS genes like SOD1, VAPB, or FUS (Kikuchi et al., 2006; Gitcho et al., 2009; Chen et al., 2010; Farg et al., 2012). The involvement of the UPR pathway in ALS has been shown in ALS patients’ post-mortem spinal cord as well as in ALS mice (Ilieva et al., 2007; Atkin et al., 2008; Sasaki, 2010). Morphological alterations such as dilation and fragmentation of rough ER have been observed in sALS patients and the mutant SOD1G93A mice (Oyanagi et al., 2008; Lautenschlaeger et al., 2012). Sasaki (2010) has observed the accumulation of misfolded proteins as a granular or amorphous material in the ER of sALS patients.

Misfolding and aberrant deposition of SOD1 are thought to be responsible for ER stress in ALS cases since mutant SOD1 is prone to misfold, co-localize with ER resident markers like glucose-related protein 78 (Grp78) and calnexin (Wate et al., 2005; Kikuchi et al., 2006). Further evidence for a close association between UPR and misfolded SOD1 deposition was provided by the findings that showed the upregulation and subsequent co-localization of an ER chaperone, protein disulphideisomerase (PDI) in ALS patients, and SOD1G93A mice (Atkin et al., 2006). Also, increased amounts of phosphorylated PERK (Atkin et al., 2006, 2008; Saxena et al., 2009), and phosphorylated eIF2α (Saxena et al., 2009) have been reported inSOD1G93A mice as well as in Neuro2a cells transfected with mutant SOD1.

Interestingly, ER stress and subsequent activation of the UPR components have been observed in the primary motor neurons exposed to the CSF of sALS patients (Vijayalakshmi et al., 2009, 2011). The CSF-induced ER stress and neurodegeneration appear to involve caspase-12 activation by the UPR pathway (Nakagawa et al., 2000; Martinez et al., 2010). Increased levels of ATF6 have been reported in ALS patients and SOD1G93A mice (Atkin et al., 2006, 2008). Oh et al. (2008) have shown the cleavage and movement of ATF6 in Neuro2a cells transfected with mutant SOD1G85R. While, Hetz et al. (2008) showed that ATF6 knockdown in NSC-34 cells transfected with mutant SOD1 increases SOD1 aggregation. Also, ALS patients and ALS mice showed increased IRE1 expression before the onset of disease (Atkin et al., 2006, 2008).

Several studies showed the involvement of C9orf72 pathogenesis in the ER stress in cell culture, primary cortical neurons, and iPSC-derived human neurons (Zhang et al., 2014; Zhang Y. J. et al., 2018; Kramer et al., 2018; Wang et al., 2019). Also, ER stress inducer tunicamycin showed a dose-dependent increase in cell death in C9-ALS iPSC-derived motoneurons, indicating altered ER proteostasis (Haeusler et al., 2014). C9orf72-ALS transcriptome studies from the human cerebellum and frontal cortex showed the upregulation of UPR genes, indicating the activation of ER stress (Prudencio et al., 2015). Dafinca et al. (2016) showed improved ER stress along with altered mitochondrial morphology and membrane potential in an iPSC-derived motor neurons from C9-ALS patients. Furthermore, an RNA sequencing study of mouse neurons having poly (PR) dipeptide repeats showed the upregulation of genes involved in ER stress, indicating that poly (PR) activates the UPR pathway (Kramer et al., 2018).

In another study by Wang et al. (2019), synthetic poly (PR) induced ER stress and inhibited the UPR mediated cell survival. Moreover, ER stress also increased the RAN translation of the G4C2 expansion, and overexpression of the G4C2 repeats decreased the global translation while increasing the stress granules formation in an eIF2α-dependent manner (Green et al., 2017). Westergard et al. (2019) have also reported the increased RAN translation and ER stress due to excitotoxic stress and optogenetic neuronal stimulation of cortical and spinal motor neurons from a C9orf72 model with (G4C2)188 repeat expansion.

A recent post-mortem study in C9-FTD patients showed increased levels of phosphorylated PERK and eIF2α in the hippocampus of C9-FTD patients and the increased levels were significantly correlated with the presence of poly (PR) pathology (Gami-Patel et al., 2021).

Therefore, integrated stress response (ISR) activation initiated by cellular stresses triggers RAN translation in cells and neurons and indicates a feed-forward loop between poly (PR) formation and the associated stress (Green et al., 2017; Cheng et al., 2018; Sonobe et al., 2018; Westergard et al., 2019). In this context, Sidrauski et al. (2013) reported that a small molecule inhibitor of ISR, ISRIB reduced poly (PR) induced toxicity. Moreover, Glineburg et al. (2021) have shown that activation of ISR by sodium arsenite-induced G4C2 repeat foci in C9orf72 patient fibroblasts. Administration of ISRIB or GSK2606414, PERK inhibitor showed strong neuroprotection in a fly model of C9orf72 pathogenesis (Zhang K. et al., 2018). Similar results were also shown in iPSC-derived motoneurons from C9-ALS cases (Zhang K. et al., 2018).

Importantly, inhibition of PKR largely reduced poly (PR) accumulation and improved behavior in C9-ALS/FTD transgenic mice (Zu et al., 2020). Overall, accumulating evidences indicate that inhibition of eIF2α phosphorylation or its downstream effects has neuroprotective consequences in the context of C9-ALS/FTD pathogenesis.

Similarly, the ER stress increased in NSC-34 cells with mutant FUS and in primary neurons expressing C9orf72-linked poly (GA) dipeptide repeats (Farg et al., 2012; Zhang et al., 2014).

Many of the ALS proteins significantly affect the UPR and/or proteostasis pathways as shown by different studies (Lin et al., 2017; Webster et al., 2017; Dafinca et al., 2021; Figure 2). ALS mutant SOD1 interacts with Derlin-1, an ER protein crucial for the ERAD pathway, and thus alters the ERAD which induces ER stress (Nishitoh et al., 2008). Vesicle-associated membrane protein-associated protein B (VAPB) is an important ER protein which is involved in the UPR activation through the IRE1 and ATF6 pathways, and mutations in VAPB cause ALS8 (Gkogkas et al., 2008; Suzuki et al., 2009). Overexpressed WT and mutant VAPBP56S interact strongly with ATF6 and decrease the transcription of XBP1, thus inducing ER stress (Suzuki et al., 2009). Indeed, knockdown of VAPB has been shown to inhibit the IRE1/XBP1 pathway, VAPB is thus involved in the activation of UPR in response to ER stress (Kanekura et al., 2006). Interestingly, Simmen et al. (2005) have shown that loss of ER/mitochondria contacts induces ER stress and the UPR, probably by disturbing some of the ER chaperones together with calnexin, calreticulin, and Sigma non-opioid intracellular receptor 1 (Sig1R; Hayashi and Su, 2007).

Figure 2.

Figure 2

Open in a new tab

ER stress and the UPR in amyotrophic lateral sclerosis (ALS). Examples of ALS-linked genes involved in ER stress and the UPR are shown in red text. ALS-associated defects to the UPR are also mentioned in red text. Adapted from Webster et al. (2017).

TDP-43 and ER Stress and UPR

Aberrant misfolding and aggregation of TDP-43 along with TDP-43 posttranslational modifications play a crucial role in the development of neurodegenerative diseases including ALS and FTD (Arai et al., 2006; Neumann et al., 2006; Igaz et al., 2008; Kumar et al., 2016b; 2019). Also, pathological aggregation of TDP-43 causes increased ER stress following the activation of apoptosis (Suzuki et al., 2011; Dafinca et al., 2021). Nuclear depletion of TDP-43 correlates with increased mislocalization of TDP-43 to the rough ER and cytoplasmic inclusion formation, indicating a dynamic relationship between the TDP-43, ER, and pathological inclusion leading to neurodegeneration (Sasaki, 2010; Vaccaro et al., 2013; Wang et al., 2015a). Later, Suzuki and Matsuoka (2012) reported that the increased endogenous levels of TDP-43 result with the increase in the expression of C/EBP-homologous protein(CHOP), largely involved in ER-facilitated apoptosis and is regulated via the PERK/eIF2a/ATF4 pathway. Walker et al. (2013) showed that both WT and mutant TDP-43Q331K/A315T significantly activate the UPR pathways through increasing the expression of the key ER stress markers, XBP1 and ATF6 in Neuro2a cells. Moreover, overexpression of TDP-43 C-terminal fragments, TDP-35, and TDP-25 increased the levels of phosphorylated-eIF2α, CHOP, and truncated caspase-12 (Wang et al., 2015b). These findings were further established by Wang et al. (2015a), who showed that overexpression of WT and TDP-43A315T in neural SH-SY5Y cells up-regulates the expression of the GRP-78, phosphorylated-eIF2α, CHOP, caspase-3, caspase-9, and caspase-12 fragments, as well as downregulates the Bcl-2 family proteins. Similarly, Hu et al. (2019) showed that overexpression of mutant TDP-43Q331K in SH-SY5Ycellsleads to increased levels of GRP-78, ATF4, CHOP, PDI, and caspase 12. Also, TDP-43Q331Kmutant enhanced Beclin1 and p62 expression, and decreased the LC3-II/LC3-I ratio, an indicative of impaired autophagy normally observed in several neurodegenerative diseases.

Pharmacological Targeting of ER Stress and UPR

The fact that ER stress is involved in ALS pathogenesis and the UPR pathway which mitigates ER stress under physiological conditions represents a key therapeutic target for interventions. The activation of the UPR signaling pathway can lead to the activation of both pro-survival and pro-apoptotic activities. Thus, modulating the UPR pathways will either stimulate alleviation of protein misfolding, or stimulate apoptosis, which would have therapeutic effects in human diseases associated with ER stress. Many studies have identified small molecules that can be considered as a potential drug to selectively inhibit UPR components and have already been enrolled in preclinical trials of disease (Kanekura et al., 2009; Saxena et al., 2009; Ciechanover and Kwon, 2015; Ruegsegger and Saxena, 2016; Dalla Bella et al., 2021).

Several small molecules targeting the different domains of the IRE1 pathway are in the preclinical stages against cancer, diabetes, neurodegenerative diseases, etc. The RNase domain inhibitors of IRE1 (e.g., MKC-3946, STF-083010) contain an aromatic aldehyde group in the core and adjacent hydroxyl group. The core aldehyde group reacts with the amino group of lysine and forms imine derivatives, and the hydroxyl group reacts with the tyrosine forming hydrogen bonds, and inhibiting the catalytic cleavage of IRE1α (Cross et al., 2012). The inhibitors targeting the kinase domain of IRE1 (e.g., KIRA6) disrupt the interfacial contacts and prevent the dimerization of IRE1α, thus making it inactive (Feldman et al., 2016). The small molecule inhibitors of the PERK pathway (e.g., GSK2606414, GSK2656157) prevent the interaction of PERK with ATP and thus block the PERK induced signaling cascade. These ATP-competitive inhibitors contain an indoline core moiety that binds to the kinase domain in the ATP-binding site, leading to a conformational change that results in the inhibition of the kinase domain of PERK (Hetz et al., 2019). Similarly, the modulators of the PERK pathway (Salubrinal, Guanabenz, and Sephin1) inhibit the protein phosphatase complex and thus prevent the de-phosphorylation of eIF2α, a negative feedback loop to control protein translation during the ER stress (Boyce et al., 2005; Tsaytler et al., 2011). Also, Salubrinal protects SOD1G93A mouse motor neurons from ER stress (Saxena et al., 2009). Guanabenz, an FDA-approved alpha-2 adrenergic receptor agonist, decreased neuronal toxicity by decreasing the ER stress in worm and zebrafish models (Vaccaro et al., 2013). Guanabenz treatment delayed the disease onset, improved motor performance, decrease the loss of motor neurons, and improve the survival in a SOD1G93A mouse model by reducing ER stress due to extensive phosphorylation ofeIF2a (Jiang et al., 2014; Wang et al., 2014; Das et al., 2015; Dalla Bella et al., 2021). In mutant TDP-43 C. elegans and zebrafish models of ALS, guanabenz, and salubrinal decreased ER stress and subsequently reduced the neurodegeneration (Vieira et al., 2015).

A summary of small molecules that selectively target crucial UPR components and other players of the ER proteostasis network, and is used to target neurodegenerative disease models is elegantly reviewed in Charif et al. (2022), Hetz et al. (2019), and Rivas et al. (2015) and is further shown in Figure 1 and Table 1.

Table 1.

Pharmacological targeting of UPR pathway (Rivas et al., 2015; Hetz et al., 2019).

Small molecules UPR pathway ER-stress
GSK2656157 PERK arm Inhibitor of PERK kinase
GSK2606414 Inhibitor of PERK kinase
Salubrinal Binding GADD34 phosphatase complex, inhibitor of eIF2a dephosphorylation
ISRIB Reduced ATF4 expression
Guanabenz eIF2a phosphatase inhibitor
Sephin1 eIF2a phosphatase inhibitor
Salicylaldimines IRE1 arm Inhibitor of IRE1α RNase
SFT-083010 Inhibitor of IRE1α RNase
MKC-3946 Inhibitor of IRE1α RNase
Sunitinib Inhibitor of IRE1α RNase
Toyocamycin Inhibitor of IRE1α RNase
Methoxycitrinin Increasing the XBP1 splicing levels
Citrinin Increasing the XBP1 splicing levels
Patulin Increasing the XBP1 splicing levels
Quercetin Increase IRE1 nuclease activityand splicing of XBP1
Apigenin Increasingthe IRE1α nuclease activity
Resveratrol Decreasing DNA-binding capacity of XBP1 to the target genes
Apigenin ATF6 arm Upregulation of ATF6 expression
Baicalein Upregulation of ATF6 expression
Kaempferol Downregulation of ATF6 expression
Open in a new tab

Conclusion

In summary, growing evidences indicate that ER stress and UPRare largely involved in the pathogenesis of human diseases, including cancer and neurodegenerative diseases. Protein misfolding and aggregation in cells trigger the ER stress which is overpowered by an adaptive response of cells collectively known as UPR. The UPR pathways are facilitated by essential components like PERK, IRE1, and ATF6 which are important in maintaining protein homeostasis. This protective role becomes more important and beneficial in several neurodegenerative diseases including ALS. Studies from ALS and other neurodegenerative disease models indicate that treatments targeting ER proteostasis and UPR have shown protective roles. Further, a more clear and improved understanding of the genes involved in ALS and the associated mechanisms of proteostasis dysfunction in ALS will be essential and crucial for developing small molecule therapeutics to effectively target the ER proteostasis and UPR.

Author Contributions

VK and YL designed the topics. CZ and AR wrote the main text with the contributions of YL and VK. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  1. Acosta-Alvear D., Zhou Y., Blais A., Tsikitis M., Lents N. H., Arias C., et al. (2007). XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol. Cell 27, 53–66. 10.1016/j.molcel.2007.06.011 [DOI] [PubMed] [Google Scholar]
  2. Al-Chalabi A., Jones A., Troakes C., King A., Al-Sarraj S., van den Berg L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 124, 339–352. 10.1007/s00401-012-1022-4 [DOI] [PubMed] [Google Scholar]
  3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602–611. 10.1016/j.bbrc.2006.10.093 [DOI] [PubMed] [Google Scholar]
  4. Atkin J. D., Farg M. A., Turner B. J., Tomas D., Lysaght J. A., Nunan J., et al. (2006). Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 281, 30152–30165. 10.1074/jbc.M603393200 [DOI] [PubMed] [Google Scholar]
  5. Atkin J. D., Farg M. A., Walker A. K., McLean C., Tomas D., Horne M. K. (2008). Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 30, 400–407. 10.1016/j.nbd.2008.02.009 [DOI] [PubMed] [Google Scholar]
  6. Bernard-Marissal N., Sunyach C., Marissal T., Raoul C., Pettmann B. (2015). Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice. Neurobiol. Dis. 73, 130–136. 10.1016/j.nbd.2014.09.009 [DOI] [PubMed] [Google Scholar]
  7. Blokhuis A. M., Groen E. J., Koppers M., van den Berg L. H., Pasterkamp R. J. (2013). Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 777–794. 10.1007/s00401-013-1125-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boyce M., Bryant K. F., Jousse C., Long K., Harding H. P., Scheuner D., et al. (2005). A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science 307, 935–939. 10.1126/science.1101902 [DOI] [PubMed] [Google Scholar]
  9. Charif S. E., Vassallu M. F., Salvanal L., Igaz L. M. (2022). Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia. Neural Regen. Res. 17, 1423–1430. 10.4103/1673-5374.330593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen H. J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., et al. (2010). Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem. 285, 40266–40281. 10.1074/jbc.M110.161398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheng W., Wang S., Mestre A. A., Fu C., Makarem A., Xian F., et al. (2018). C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2α phosphorylation. Nat. Commun. 9:51. 10.1038/s41467-017-02495-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cicardi M. E., Marrone L., Azzouz M., Trotti D. (2021). Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J. 40:e106389. 10.15252/embj.2020106389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ciechanover A., Kwon Y. T. (2015). Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp. Mol. Med. 47:e147. 10.1038/emm.2014.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cooper-Knock J., Harvey C., Zhang S., Moll T., Timpanaro I. S., Kenna K. P., et al. (2021). Advances in the genetic classification of amyotrophic lateral sclerosis. Curr. Opin. Neurol. 34, 756–764. 10.1097/WCO.0000000000000986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cross B. C., Bond P. J., Sadowski P. G., Jha B. K., Zak J., Goodman J. M., et al. (2012). The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl. Acad. Sci. U S A 109, E869–878. 10.1073/pnas.1115623109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dafinca R., Barbagallo P., Talbot K. (2021). The role of mitochondrial dysfunction and ER stress in TDP-43 and C9ORF72 ALS. Front. Cell Neurosci. 15:653688. 10.3389/fncel.2021.653688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dafinca R., Scaber J., Ababneh N., Lalic T., Weir G., Christian H., et al. (2016). C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem Cells 34, 2063–2078. 10.1002/stem.2388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dalla Bella E., Bersano E., Antonini G., Borghero G., Capasso M., Caponnetto C., et al. (2021). The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial. Brain 144, 2635–2647. 10.1093/brain/awab167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Das I., Krzyzosiak A., Schneider K., Wrabetz L., D’Antonio M., Barry N., et al. (2015). Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348, 239–242. 10.1126/science.aaa4484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. de Mena L., Lopez-Scarim J., Rincon-Limas D. E. (2021). TDP-43 and ER stress in neurodegeneration: friends or foes? Front. Mol. Neurosci. 14:772226. 10.3389/fnmol.2021.772226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Deng H. X., Chen W., Hong S. T., Boycott K. M., Gorrie G. H., Siddique N., et al. (2011). Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211–215. 10.1038/nature10353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dugger B. N., Dickson D. W. (2017). Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9:a028035. 10.1101/cshperspect.a028035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Farg M. A., Soo K. Y., Walker A. K., Pham H., Orian J., Horne M. K., et al. (2012). Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol. Aging 33, 2855–2868. 10.1016/j.neurobiolaging.2012.02.009 [DOI] [PubMed] [Google Scholar]
  24. Feldman H. C., Tong M., Wang L., Meza-Acevedo R., Gobillot T. A., Lebedev I., et al. (2016). Structural and functional analysis of the allosteric inhibition of IRE1alpha with ATP-competitive ligands. ACS Chem. Biol. 11, 2195–2205. 10.1021/acschembio.5b00940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ferraiuolo L., Kirby J., Grierson A. J., Sendtner M., Shaw P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616–630. 10.1038/nrneurol.2011.152 [DOI] [PubMed] [Google Scholar]
  26. Gami-Patel P., van Dijken I., Meeter L. H., Melhem S., Morrema T. H. J., Scheper W., et al. (2021). Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells. Brain Pathol. 31, 163–173. 10.1111/bpa.12894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gitcho M. A., Strider J., Carter D., Taylor-Reinwald L., Forman M. S., Goate A. M., et al. (2009). VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J. Biol. Chem. 284, 12384–12398. 10.1074/jbc.M900992200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gkogkas C., Middleton S., Kremer A. M., Wardrope C., Hannah M., Gillingwater T. H., et al. (2008). VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 17, 1517–1526. 10.1093/hmg/ddn040 [DOI] [PubMed] [Google Scholar]
  29. Glineburg M. R., Zhang Y., Krans A., Tank E. M., Barmada S. J., Todd P. K. (2021). Enhanced detection of expanded repeat mRNA foci with hybridization chain reaction. Acta Neuropathol. Commun. 9:73. 10.1186/s40478-021-01169-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Green K. M., Glineburg M. R., Kearse M. G., Flores B. N., Linsalata A. E., Fedak S. J., et al. (2017). RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun. 8:2005. 10.1038/s41467-017-02200-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Haeusler A. R., Donnelly C. J., Periz G., Simko E. A., Shaw P. G., Kim M. S., et al. (2014). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195–200. 10.1038/nature13124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Harding H. P., Zhang Y., Ron D. (1999). Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271–274. 10.1038/16729 [DOI] [PubMed] [Google Scholar]
  33. Hayashi T., Su T. P. (2007). Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131, 596–610. 10.1016/j.cell.2007.08.036 [DOI] [PubMed] [Google Scholar]
  34. Haze K., Yoshida H., Yanagi H., Yura T., Mori K. (1999). Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 10, 3787–3799. 10.1091/mbc.10.11.3787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hetz C. (2012). The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89–102. 10.1038/nrm3270 [DOI] [PubMed] [Google Scholar]
  36. Hetz C., Axten J. M., Patterson J. B. (2019). Pharmacological targeting of the unfolded protein response for disease intervention. Nat. Chem. Biol. 15, 764–775. 10.1038/s41589-019-0326-2 [DOI] [PubMed] [Google Scholar]
  37. Hetz C., Lee A. H., Gonzalez-Romero D., Thielen P., Castilla J., Soto C., et al. (2008). Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc. Natl. Acad. Sci. U S A 105, 757–762. 10.1073/pnas.0711094105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hetz C., Papa F. R. (2018). The unfolded protein response and cell fate control. Mol. Cell 69, 169–181. 10.1016/j.molcel.2017.06.017 [DOI] [PubMed] [Google Scholar]
  39. Hetz C., Saxena S. (2017). ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 13, 477–491. 10.1038/nrneurol.2017.99 [DOI] [PubMed] [Google Scholar]
  40. Hu W., Liu X., Wang S., Sun G., Zhao R., Lu H. (2019). SecinH3 attenuates TDP-43 p.Q331K-induced neuronal toxicity by suppressing endoplasmic reticulum stress and enhancing autophagic flux. IUBMB Life 71, 192–199. 10.1002/iub.1951 [DOI] [PubMed] [Google Scholar]
  41. Igaz L. M., Kwong L. K., Xu Y., Truax A. C., Uryu K., Neumann M., et al. (2008). Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182–194. 10.2353/ajpath.2008.080003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ilieva E. V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., et al. (2007). Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130, 3111–3123. 10.1093/brain/awm190 [DOI] [PubMed] [Google Scholar]
  43. Jiang H. Q., Ren M., Jiang H. Z., Wang J., Zhang J., Yin X., et al. (2014). Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 277, 132–138. 10.1016/j.neuroscience.2014.03.047 [DOI] [PubMed] [Google Scholar]
  44. Kanekura K., Nishimoto I., Aiso S., Matsuoka M. (2006). Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem. 281, 30223–30233. 10.1074/jbc.M605049200 [DOI] [PubMed] [Google Scholar]
  45. Kanekura K., Suzuki H., Aiso S., Matsuoka M. (2009). ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol. Neurobiol. 39, 81–89. 10.1007/s12035-009-8054-3 [DOI] [PubMed] [Google Scholar]
  46. Kaushik S., Cuervo A. M. (2015). Proteostasis and aging. Nat. Med. 21, 1406–1415. 10.1038/nm.4001 [DOI] [PubMed] [Google Scholar]
  47. Kikuchi H., Almer G., Yamashita S., Guegan C., Nagai M., Xu Z., et al. (2006). Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. U S A 103, 6025–6030. 10.1073/pnas.0509227103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Koppers M., van Blitterswijk M. M., Vlam L., Rowicka P. A., van Vught P. W., Groen E. J., et al. (2012). VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33, e7837–e7913. 10.1016/j.neurobiolaging.2011.10.006 [DOI] [PubMed] [Google Scholar]
  49. Kramer N. J., Haney M. S., Morgens D. W., Jovicic A., Couthouis J., Li A., et al. (2018). CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 50, 603–612. 10.1038/s41588-018-0070-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Krebs J., Agellon L. B., Michalak M. (2015). Ca2+ homeostasis and endoplasmic reticulum (ER) stress: an integrated view of calcium signaling. Biochem. Biophys. Res. Commun. 460, 114–121. 10.1016/j.bbrc.2015.02.004 [DOI] [PubMed] [Google Scholar]
  51. Kumar V., Islam A., Hassan M. I., Ahmad F. (2016a). Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. Eur. J. Med. Chem. 121, 903–917. 10.1016/j.ejmech.2016.06.017 [DOI] [PubMed] [Google Scholar]
  52. Kumar V., Sami N., Kashav T., Islam A., Ahmad F., Hassan M. I. (2016b). Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur. J. Med. Chem. 124, 1105–1120. 10.1016/j.ejmech.2016.07.054 [DOI] [PubMed] [Google Scholar]
  53. Kumar V., Wahiduzzaman W., Prakash A., Tomar A. K., Srivastava A., Kundu B., et al. (2019). Exploring the aggregation-prone regions from structural domains of human TDP-43. Biochim. Biophys. Acta Proteins Proteomics 1867, 286–296. 10.1016/j.bbapap.2018.10.008 [DOI] [PubMed] [Google Scholar]
  54. Kwiatkowski T. J., Jr., Bosco D. A., Leclerc A. L., Tamrazian E., Vanderburg C. R., Russ C., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205–1208. 10.1126/science.1166066 [DOI] [PubMed] [Google Scholar]
  55. Lautenschlaeger J., Prell T., Grosskreutz J. (2012). Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 13, 166–177. 10.3109/17482968.2011.641569 [DOI] [PubMed] [Google Scholar]
  56. Levy J. R., Sumner C. J., Caviston J. P., Tokito M. K., Ranganathan S., Ligon L. A., et al. (2006). A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J. Cell Biol. 172, 733–745. 10.1083/jcb.200511068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Lin G., Mao D., Bellen H. J. (2017). Amyotrophic lateral sclerosis pathogenesis converges on defects in protein homeostasis associated with TDP-43 mislocalization and proteasome-mediated degradation overload. Curr. Top. Dev. Biol. 121, 111–171. 10.1016/bs.ctdb.2016.07.004 [DOI] [PubMed] [Google Scholar]
  58. Lin J. H., Walter P., Yen T. S. (2008). Endoplasmic reticulum stress in disease pathogenesis. Annu. Rev. Pathol. 3, 399–425. 10.1146/annurev.pathmechdis.3.121806.151434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Liu C. Y., Wong H. N., Schauerte J. A., Kaufman R. J. (2002). The protein kinase/endoribonuclease IRE1α that signals the unfolded protein response has a luminal N-terminal ligand-independent dimerization domain. J. Biol. Chem. 277, 18346–18356. 10.1074/jbc.M112454200 [DOI] [PubMed] [Google Scholar]
  60. Mackenzie I. R., Bigio E. H., Ince P. G., Geser F., Neumann M., Cairns N. J., et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427–434. 10.1002/ana.21147 [DOI] [PubMed] [Google Scholar]
  61. Malhotra J. D., Kaufman R. J. (2007). The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 18, 716–731. 10.1016/j.semcdb.2007.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Martinez J. A., Zhang Z., Svetlov S. I., Hayes R. L., Wang K. K., Larner S. F. (2010). Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells. Apoptosis 15, 1480–1493. 10.1007/s10495-010-0526-4 [DOI] [PubMed] [Google Scholar]
  63. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., et al. (2010). Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223–226. 10.1038/nature08971 [DOI] [PubMed] [Google Scholar]
  64. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., et al. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98–103. 10.1038/47513 [DOI] [PubMed] [Google Scholar]
  65. Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133. 10.1126/science.1134108 [DOI] [PubMed] [Google Scholar]
  66. Nishihira Y., Tan C. F., Hoshi Y., Iwanaga K., Yamada M., Kawachi I., et al. (2009). Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol. 117, 45–53. 10.1007/s00401-008-0443-6 [DOI] [PubMed] [Google Scholar]
  67. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., et al. (2008). ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22, 1451–1464. 10.1101/gad.1640108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Oakes S. A., Papa F. R. (2015). The role of endoplasmic reticulum stress in human pathology. Annu. Rev. Pathol. 10, 173–194. 10.1146/annurev-pathol-012513-104649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Oh Y. K., Shin K. S., Yuan J., Kang S. J. (2008). Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells. J. Neurochem. 104, 993–1005. 10.1111/j.1471-4159.2007.05053.x [DOI] [PubMed] [Google Scholar]
  70. Oyanagi K., Yamazaki M., Takahashi H., Watabe K., Wada M., Komori T., et al. (2008). Spinal anterior horn cells in sporadic amyotrophic lateral sclerosis show ribosomal detachment from and cisternal distention of the rough endoplasmic reticulum. Neuropathol. Appl. Neurobiol. 34, 650–658. 10.1111/j.1365-2990.2008.00941.x [DOI] [PubMed] [Google Scholar]
  71. Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B. K. (2019). Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12:25. 10.3389/fnmol.2019.00025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Prudencio M., Belzil V. V., Batra R., Ross C. A., Gendron T. F., Pregent L. J., et al. (2015). Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 18, 1175–1182. 10.1038/nn.4065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Rivas A., Vidal R. L., Hetz C. (2015). Targeting the unfolded protein response for disease intervention. Expert Opin. Ther. Targets 19, 1203–1218. 10.1517/14728222.2015.1053869 [DOI] [PubMed] [Google Scholar]
  74. Ruegsegger C., Saxena S. (2016). Proteostasis impairment in ALS. Brain Res. 1648, 571–579. 10.1016/j.brainres.2016.03.032 [DOI] [PubMed] [Google Scholar]
  75. Sasaki S. (2010). Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 69, 346–355. 10.1097/NEN.0b013e3181d44992 [DOI] [PubMed] [Google Scholar]
  76. Saxena S., Cabuy E., Caroni P. (2009). A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12, 627–636. 10.1038/nn.2297 [DOI] [PubMed] [Google Scholar]
  77. Scheper W., Hoozemans J. J. (2015). The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol. 130, 315–331. 10.1007/s00401-015-1462-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Schroder M. (2008). Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 65, 862–894. 10.1007/s00018-007-7383-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Shatunov A., Al-Chalabi A. (2021). The genetic architecture of ALS. Neurobiol. Dis. 147:105156. 10.1016/j.nbd.2020.105156 [DOI] [PubMed] [Google Scholar]
  80. Sidrauski C., Acosta-Alvear D., Khoutorsky A., Vedantham P., Hearn B. R., Li H., et al. (2013). Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife 2:e00498. 10.7554/eLife.00498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Simmen T., Aslan J. E., Blagoveshchenskaya A. D., Thomas L., Wan L., Xiang Y., et al. (2005). PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J. 24, 717–729. 10.1038/sj.emboj.7600559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sonobe Y., Ghadge G., Masaki K., Sendoel A., Fuchs E., Roos R. P. (2018). Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 116, 155–165. 10.1016/j.nbd.2018.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Suzuki H., Kanekura K., Levine T. P., Kohno K., Olkkonen V. M., Aiso S., et al. (2009). ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem. 108, 973–985. 10.1111/j.1471-4159.2008.05857.x [DOI] [PubMed] [Google Scholar]
  84. Suzuki H., Lee K., Matsuoka M. (2011). TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage. J. Biol. Chem. 286, 13171–13183. 10.1074/jbc.M110.197483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Suzuki H., Matsuoka M. (2012). TDP-43 toxicity is mediated by the unfolded protein response-unrelated induction of C/EBP homologous protein expression. J. Neurosci. Res. 90, 641–647. 10.1002/jnr.22777 [DOI] [PubMed] [Google Scholar]
  86. Tabas I., Ron D. (2011). Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184–190. 10.1038/ncb0311-184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Tsai Y. L., Manley J. L. (2021). Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death. Cell Cycle 20, 631–646. 10.1080/15384101.2021.1886661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Tsaytler P., Harding H. P., Ron D., Bertolotti A. (2011). Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332, 91–94. 10.1126/science.1201396 [DOI] [PubMed] [Google Scholar]
  89. Tziortzouda P., Van Den Bosch L., Hirth F. (2021). Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197–208. 10.1038/s41583-021-00431-1 [DOI] [PubMed] [Google Scholar]
  90. Vaccaro A., Patten S. A., Aggad D., Julien C., Maios C., Kabashi E., et al. (2013). Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol. Dis. 55, 64–75. 10.1016/j.nbd.2013.03.015 [DOI] [PubMed] [Google Scholar]
  91. van Es M. A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R. J., Veldink J. H., et al. (2017). Amyotrophic lateral sclerosis. Lancet 390, 2084–2098. 10.1016/S0140-6736(17)31287-4 [DOI] [PubMed] [Google Scholar]
  92. Vance C., Rogelj B., Hortobagyi T., De Vos K. J., Nishimura A. L., Sreedharan J., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208–1211. 10.1126/science.1165942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Vieira F. G., Ping Q., Moreno A. J., Kidd J. D., Thompson K., Jiang B., et al. (2015). Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS. PLoS One 10:e0135570. 10.1371/journal.pone.0135570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Vijayalakshmi K., Alladi P. A., Ghosh S., Prasanna V. K., Sagar B. C., Nalini A., et al. (2011). Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Dis. 41, 695–705. 10.1016/j.nbd.2010.12.005 [DOI] [PubMed] [Google Scholar]
  95. Vijayalakshmi K., Alladi P. A., Sathyaprabha T. N., Subramaniam J. R., Nalini A., Raju T. R. (2009). Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Res. 1263, 122–133. 10.1016/j.brainres.2009.01.041 [DOI] [PubMed] [Google Scholar]
  96. Walker A. K., Atkin J. D. (2011). Stress signaling from the endoplasmic reticulum: a central player in the pathogenesis of amyotrophic lateral sclerosis. IUBMB Life 63, 754–763. 10.1002/iub.520 [DOI] [PubMed] [Google Scholar]
  97. Walker A. K., Soo K. Y., Sundaramoorthy V., Parakh S., Ma Y., Farg M. A., et al. (2013). ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS One 8:e81170. 10.1371/journal.pone.0081170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Walter P., Ron D. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081–1086. 10.1126/science.1209038 [DOI] [PubMed] [Google Scholar]
  99. Wang L., Popko B., Tixier E., Roos R. P. (2014). Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 71, 317–324. 10.1016/j.nbd.2014.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Wang X., Ma M., Teng J., Che X., Zhang W., Feng S., et al. (2015a). Valproate attenuates 25-kDa C-terminal fragment of TDP-43-induced neuronal toxicity via suppressing endoplasmic reticulum stress and activating autophagy. Int. J. Biol. Sci. 11, 752–761. 10.7150/ijbs.11880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Wang X., Zhou S., Ding X., Ma M., Zhang J., Zhou Y., et al. (2015b). Activation of ER stress and autophagy induced by TDP-43 A315T as pathogenic mechanism and the corresponding histological changes in skin as potential biomarker for ALS with the mutation. Int. J. Biol. Sci. 11, 1140–1149. 10.7150/ijbs.12657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Wang R., Xu X., Hao Z., Zhang S., Wu D., Sun H., et al. (2019). Poly-PR in C9ORF72-related amyotrophic lateral sclerosis/frontotemporal dementia causes neurotoxicity by clathrin-dependent endocytosis. Neurosci. Bull. 35, 889–900. 10.1007/s12264-019-00395-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Wate R., Ito H., Zhang J. H., Ohnishi S., Nakano S., Kusaka H. (2005). Expression of an endoplasmic reticulum-resident chaperone, glucose-regulated stress protein 78, in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. 110, 557–562. 10.1007/s00401-005-1080-y [DOI] [PubMed] [Google Scholar]
  104. Webster C. P., Smith E. F., Shaw P. J., De Vos K. J. (2017). Protein homeostasis in amyotrophic lateral sclerosis: therapeutic opportunities? Front. Mol. Neurosci. 10:123. 10.3389/fnmol.2017.00123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Westergard T., McAvoy K., Russell K., Wen X., Pang Y., Morris B., et al. (2019). Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress. EMBO Mol. Med. 11:e9423. 10.15252/emmm.201809423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Zhang K., Daigle J. G., Cunningham K. M., Coyne A. N., Ruan K., Grima J. C., et al. (2018). Stress granule assembly disrupts nucleocytoplasmic transport. Cell 173, 958–971.e17. 10.1016/j.cell.2018.03.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Zhang Y. J., Gendron T. F., Ebbert M. T. W., O’Raw A. D., Yue M., Jansen-West K., et al. (2018). Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 24, 1136–1142. 10.1038/s41591-018-0071-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Zhang Y. J., Jansen-West K., Xu Y. F., Gendron T. F., Bieniek K. F., Lin W. L., et al. (2014). Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 128, 505–524. 10.1007/s00401-014-1336-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Zu T., Guo S., Bardhi O., Ryskamp D. A., Li J., Khoramian Tusi S., et al. (2020). Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. U S A 117, 18591–18599. 10.1073/pnas.2005748117 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Aging Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES